Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence.

作者: L. Lalanne , G. Ayranci , D. Filliol , C. Gavériaux-Ruff , K. Befort

DOI: 10.1111/ADB.12392

关键词:

摘要: Addiction is a chronic brain disorder that progressively invades all aspects of personal life. Accordingly, addiction to opiates severely impairs interpersonal relationships, and the resulting social isolation strongly contributes severity chronicity disease. Uncovering new therapeutic strategies address this aspect therefore great clinical relevance. We recently established mouse model heroin in which, following exposure, 'abstinent' mice develop strong long-lasting avoidance phenotype. Here, we explored compared efficacy two pharmacological interventions model. Because studies indicate some antidepressants on emotional dysfunction associated with addiction, first used 4-week treatment serotonergic antidepressant fluoxetine, as reference. In addition, considering prodepressant effects kappa opioid receptor signaling, also investigated antagonist norbinaltorphimine (norBNI). Finally, assessed whether fluoxetine norBNI could reverse abstinence-induced after it has established. Altogether, our results show interspaced administrations are sufficient both prevent impairment abstinent animals. Therefore, antagonism may represent useful approach alleviate addicted individuals.

参考文章(57)
Benjamin Kest, Eileen Hopkins, Christina A Palmese, Michael Adler, Jeffrey S Mogil, Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains. Pharmacology, Biochemistry and Behavior. ,vol. 73, pp. 821- 828 ,(2002) , 10.1016/S0091-3057(02)00908-5
Gui-Ying Zan, Qian Wang, Yu-Jun Wang, Yao Liu, Ai Hang, Xiao-Hong Shu, Jing-Gen Liu, Antagonism of κ opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence. Behavioural Brain Research. ,vol. 291, pp. 334- 341 ,(2015) , 10.1016/J.BBR.2015.05.053
A E Takemori, J L Vaught, Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. Journal of Pharmacology and Experimental Therapeutics. ,vol. 208, pp. 86- 90 ,(1979)
Celia Goeldner, Pierre-Eric Lutz, Emmanuel Darcq, Thomas Halter, Daniel Clesse, Abdel-Mouttalib Ouagazzal, Brigitte L. Kieffer, Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine. Biological Psychiatry. ,vol. 69, pp. 236- 244 ,(2011) , 10.1016/J.BIOPSYCH.2010.08.021
Pierre-Eric Lutz, Amynah A. Pradhan, Celia Goeldner, Brigitte L. Kieffer, Sequential and opposing alterations of 5-HT1A receptor function during withdrawal from chronic morphine European Neuropsychopharmacology. ,vol. 21, pp. 835- 840 ,(2011) , 10.1016/J.EURONEURO.2011.02.002
Olivier George, George F. Koob, Leandro F. Vendruscolo, Negative reinforcement via motivational withdrawal is the driving force behind the transition to addiction Psychopharmacology. ,vol. 231, pp. 3911- 3917 ,(2014) , 10.1007/S00213-014-3623-1
M.R. Bruchas, B.B. Land, C. Chavkin, The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors Brain Research. ,vol. 1314, pp. 44- 55 ,(2010) , 10.1016/J.BRAINRES.2009.08.062
Edward V. Nunes, Frances R. Levin, Treating depression in substance abusers Current Psychiatry Reports. ,vol. 8, pp. 363- 370 ,(2006) , 10.1007/S11920-006-0037-8
Laurence Lalanne, Gulebru Ayranci, Brigitte L. Kieffer, Pierre-Eric Lutz, The kappa opioid receptor: from addiction to depression, and back. Frontiers in Psychiatry. ,vol. 5, pp. 170- 170 ,(2014) , 10.3389/FPSYT.2014.00170